Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases [1]

Nephron

Volumn 89, Issue 4, 2001, Pages 467-468

  Janssen Van Doorn, K ^a   Neyns, B ^a   Van Der Niepen, P ^a   Verbeelen, D ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PAMIDRONIC ACID; TRAMADOL;

AGED; ANAMNESIS; BONE METASTASIS; BREAST CARCINOMA; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONCENTRATION RESPONSE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DRUG INFUSION; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; HYDRONEPHROSIS; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LETTER; NEPHROTOXICITY; OSTEOLYSIS; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; ULTRASOUND;

AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; NEPHRITIS, INTERSTITIAL;

EID: 0035200403     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046123     Document Type: Letter

References (5)

1. The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases
2. Acute renal failure associated with the administration of parenteral etidronate
3. Renal failure associated with intravenous diphosphonates
4. Adverse effects of bisphosphonates: A comparative review
5. The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture